These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2252528)

  • 1. Lymphocyte transfusion in recent onset type I diabetes mellitus--a one-year follow-up of cell-mediated anti-islet cytotoxicity and C-peptide secretion.
    Krug J; Verlohren HJ; Bierwolf B; Lampeter E; Borte M; Nietzschmann U; Haustein B; Lohmann D
    J Autoimmun; 1990 Oct; 3(5):601-9. PubMed ID: 2252528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-pancreatic immunity. In vitro studies of cellular and humoral immune reactions directed toward pancreatic islets.
    Boitard C; Saï P; Debray-Sachs M; Assan R; Hamburger J
    Clin Exp Immunol; 1984 Mar; 55(3):571-80. PubMed ID: 6368060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between residual beta-cell function and islet cell antibodies in newly diagnosed type I diabetes. Follow-up study.
    Peig M; Gomis R; Ercilla G; Casamitjana R; Bottazzo GF; Pujol-Borrell R
    Diabetes; 1989 Nov; 38(11):1396-401. PubMed ID: 2695374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific immunotherapy in insulin-dependent diabetes mellitus (preliminary report).
    Lohmann D; Bierwolf B; Krug J; Lampeter E; Verlohren HJ
    Exp Clin Endocrinol; 1986 Aug; 87(3):333-6. PubMed ID: 3536537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of anti-islet ADCC after manifestation of type-1 (insulin-dependent) diabetes.
    Köhler E; Knospe S; Besch W; Michaelis D; Rjasanowski I
    Exp Clin Endocrinol; 1989; 94(3):357-62. PubMed ID: 2698355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defect of cellular suppressor function in the pathogenesis of type I diabetes mellitus.
    Lohmann D; Lampeter E; Krug J; Bierwolf B; Verlohren HJ
    Exp Clin Endocrinol; 1987 Aug; 89(3):340-4. PubMed ID: 2959493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early deficits in insulin secretion, beta cell mass and islet blood perfusion precede onset of autoimmune type 1 diabetes in BioBreeding rats.
    Medina A; Parween S; Ullsten S; Vishnu N; Siu YT; Quach M; Bennet H; Balhuizen A; Åkesson L; Wierup N; Carlsson PO; Ahlgren U; Lernmark Å; Fex M
    Diabetologia; 2018 Apr; 61(4):896-905. PubMed ID: 29209740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated T-lymphocytes in newly diagnosed type I diabetic patients: relationship to residual beta cell function.
    Binimelis J; Codina M; Oriola J; Amill B; Perez A; de Leiva A
    J Autoimmun; 1990 Oct; 3(5):579-85. PubMed ID: 2147547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients.
    Kruszynska YT; Goulas S; Wollen N; McIntyre N
    J Hepatol; 1998 Feb; 28(2):280-91. PubMed ID: 9514541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cell and islet killer cell activities in type 1 (insulin-dependent) diabetes.
    Negishi K; Waldeck N; Chandy G; Buckingham B; Kershnar A; Fisher L; Gupta S; Charles MA
    Diabetologia; 1986 Jun; 29(6):352-7. PubMed ID: 3527835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diazoxide treatment at onset preserves residual insulin secretion in adults with autoimmune diabetes.
    Björk E; Berne C; Kämpe O; Wibell L; Oskarsson P; Karlsson FA
    Diabetes; 1996 Oct; 45(10):1427-30. PubMed ID: 8826981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-Peptide reserve in insulin-dependent diabetes. Comparative responses to glucose, glucagon and tolbutamide.
    Mirel RD; Ginsberg-Fellner F; Horwitz DL; Rayfield EJ
    Diabetologia; 1980 Sep; 19(3):183-8. PubMed ID: 6997119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans.
    Charles MA; Suzuki M; Waldeck N; Dodson LE; Slater L; Ong K; Kershnar A; Buckingham B; Golden M
    J Immunol; 1983 Mar; 130(3):1189-94. PubMed ID: 6337213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute insulin response to intravenous glucose, glucagon and arginine in some subjects at risk for type 1 (insulin-dependent) diabetes mellitus.
    Bardet S; Rohmer V; Maugendre D; Marre M; Semana G; Limal JM; Allannic H; Charbonnel B; Saï P
    Diabetologia; 1991 Sep; 34(9):648-54. PubMed ID: 1955097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased reduction in fasting C-peptide is associated with islet cell antibodies in type 1 (insulin-dependent) diabetic patients.
    Marner B; Agner T; Binder C; Lernmark A; Nerup J; Mandrup-Poulsen T; Walldorff S
    Diabetologia; 1985 Dec; 28(12):875-80. PubMed ID: 3912242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a short prednisone regime at clinical onset of type 1 diabetes.
    Goday A; Pujol-Borrell R; Fernandez J; Casamitjana R; Rios M; Vilardell E; Gomis R
    Diabetes Res Clin Pract; 1993 Apr; 20(1):39-46. PubMed ID: 8344127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
    Greenbaum CJ; Prigeon RL; D'Alessio DA
    Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of cells responsible for the suppression of anti-beta-cell cytotoxicity in type I (insulin-dependent) diabetes mellitus.
    Krug J; Bierwolf B; Lampeter E; Verlohren HJ; Lohmann D
    Clin Exp Immunol; 1991 Apr; 84(1):43-7. PubMed ID: 1826646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electron microscopical investigations on lymphocyte cytotoxicity against beta-cells in recent onset IDDM.
    Lampeter E; Bierwolf B; Krug J; Verlohren HJ; Lohmann D; Cossel L
    Diabetes Res; 1987 Dec; 6(4):159-67. PubMed ID: 3329076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.